Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion type Assertion NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_head.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion evidence source_evidence_literature NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion SIO_000772 16232198 NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion wasDerivedFrom befree-2016 NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.
- NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_assertion wasGeneratedBy ECO_0000203 NP518493.RAVlZpmRsbnVlbdQguIuPbr3KEs3--5qbGEZWPHT5Axy0130_provenance.